封面
市場調查報告書
商品編碼
1708464

腎臟去神經支配設備市場(依手術類型、最終用戶和地區)

Renal Denervation Devices Market, By Procedure Type, By End User, By Region

出版日期: | 出版商: Coherent Market Insights | 英文 138 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球腎臟去神經支配設備市場規模估計為 12.534 億美元,預計到 2032 年將達到 32.736 億美元,2025 年至 2032 年的年複合成長率(CAGR)為 14.7%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 12.534億美元
效能數據 2020-2024 預測期 2025-2032
預測期:2025-2032年複合年成長率: 14.70% 2032年價值預測 32.736億美元
數字。 2025年腎臟去神經支配裝置各地區市場佔有率(%)
腎臟去神經支配設備市場-IMG1

腎臟去神經支配術是一種微創手術,旨在減少腎臟的交感神經活動。導管穿過動脈進入腎動脈,為腎臟供血。然後它將能量傳遞到血管壁的神經,以破壞導致高血壓的訊號。能量可以透過多種方式傳遞,包括射頻消融術、超音波以及最近基於化學物質直接注射或經皮輸送系統的新技術。腎臟去神經支配的理論基礎是腎臟在血壓調節中扮演關鍵角色的認知。腎神經過度活躍會導致全身血壓升高。透過阻斷這些過度活躍的神經通路,腎臟去神經支配術可能有助於持續降低其他治療方法失敗患者的血壓。這種治療方法在早期臨床試驗中顯示出良好的前景,但在隨後的幾次臨床試驗中卻結果不一。儘管如此,該醫療設備仍在繼續研究和開發,目前正在進行評估其安全性和有效性的臨床試驗。

市場動態:

預計腎臟去神經支配設備市場在預測期內(2024-2030 年)將顯著成長。多種因素推動了市場成長,包括高血壓盛行率的上升。此外,預計創新產品核准的增加也將在預測期內推動市場成長。例如,醫療設備公司 Kalos Medical 獲得了 467 萬韓元(約 350 萬美元)的津貼,用於推進治療高血壓的腎臟去神經支配醫療設備的開發。

本研究的主要特點

  • 本研究報告對全球腎臟去神經支配裝置市場進行了詳細分析,包括市場規模、預測期(2025-2032 年)的複合年成長率(以 2024 年為基準年)。
  • 它還強調了各個領域的潛在收益成長機會,並說明了該市場的引人注目的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 全球腎臟去神經支配裝置市場的主要企業根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行分析。
  • 研究涉及的主要企業包括美敦力、Recor Medical、波士頓科學公司、Kona Medical、Terumo Corporation、雅培和 Ablative Solutions。
  • 本報告的見解將使企業負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 全球腎臟去神經支配裝置市場報告針對行業中的各個相關人員,例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
  • 相關人員可以透過用於分析全球腎臟去神經支配設備市場的各種策略矩陣來更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
  • 急性腔室症候群症候群盛行率不斷上升
  • 技術進步
    • 限制因素
  • 複雜的法規結構
    • 機會
  • 新興經濟體尚未開發的潛力
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景

4. 全球腎臟去神經支配裝置市場-冠狀病毒(COVID-19)大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 2020 年至 2032 年全球腎臟去神經支配裝置市場(依手術類型)

  • 經皮腎去神經支配術
  • 射頻腎去神經支配術
  • 超音波腎去神經支配術
  • 其他

6. 2020 年至 2032 年全球腎臟去神經支配設備市場(依最終用戶分類)

  • 醫院
  • 診所
  • 門診手術中心
  • 其他

7. 2020 年至 2032 年全球腎臟去神經支配設備市場(按地區)

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東
  • 非洲
  • 南非
  • 中部非洲
  • 北非

第8章 競爭態勢

  • Medtronic
  • Recor Medical, Inc.
  • Boston Scientific Corp
  • Kona Medical
  • Terumo Corporation
  • Abbott
  • Ablative Solutions
  • Others

第9章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI798

Global Renal Denervation Devices Market is estimated to be valued at USD 1,253.4 Mn in 2025 and is expected to reach USD 3,273.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 14.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 1,253.4 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 14.70% 2032 Value Projection: USD 3,273.6 Mn
Figure. Renal Denervation Devices Market Share (%), By Region 2025
Renal Denervation Devices Market - IMG1

Renal denervation is a minimally invasive procedure that aims to decrease the sympathetic nerve activity to the kidneys. It involves threading a catheter through the arteries until it reaches the renal arteries, which supplies blood to the kidneys. The device then delivers energy to the nerves in the vessel wall to disrupt the signals that can cause high blood pressure. The energy can be delivered through various methods, such as radiofrequency ablation, ultrasound, and more recently, direct injection of chemicals or new methodologies based on percutaneous delivery systems. The rationale behind renal denervation comes from the understanding that the kidneys play a significant role in blood pressure regulation. Overactive renal nerves can lead to increased systemic blood pressure. By disrupting these overactive nerve pathways, renal denervation can potentially help to sustainably lower blood pressure in people for whom other treatments have failed. Although the procedure showed promise in early clinical trials, some subsequent trials had mixed results, which led to further investigations to better understand the patient populations that may benefit and to optimize the technique. Nonetheless, the devices continue to be studied and developed, with ongoing clinical trials evaluating their safety and efficacy.

Market Dynamics:

The renal denervation devices market is expected to witness significant growth during the forecast period (2024-2030). Several factors contribute to the market growth including the rising prevalence of hypertension. Additionally, the increasing approval of innovative products is expected to propel the market growth over the forecast period. For instance, Kalos Medical, a medical device company, received a grant of Won4.67m (approximately $3.5m) to advance the development of its renal denervation medical device to treat hypertension.

Key Features of the Study:

  • This report provides an in-depth analysis of the global renal denervation devices market, including market size (in US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), with 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • Key players in the global renal denervation devices market are profiled based on parameters such as company highlights, product portfolio, key highlights, financial performance, and strategies
  • Key companies covered in this study include Medtronic, Recor Medical, Inc., Boston Scientific Corp, Kona Medical, Terumo Corporation, Abbott, Ablative Solutions, and others
  • Insights from this report would enable marketers and management authorities of companies to make informed decisions regarding future product launches, product upgrades, market expansion, and marketing tactics.
  • The global renal denervation devices market report caters to various stakeholders in the industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global renal denervation devices market

Renal Denervation Devices Market Segmentation

  • By Procedure Type
    • Percutaneous Renal Denervation
    • Radiofrequency Renal Denervation
    • Ultrasound Renal Denervation
    • Others
  • By End User
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Medtronic
    • Recor Medical, Inc
    • Boston Scientific Corp
    • Kona Medical
    • Terumo Corporation
    • Abbott
    • Ablative Solutions
    • Others

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Procedure Type
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing prevalence of acute compartment syndrome
  • Technological Advancement
    • Restraints
  • Complex Regulatory Framework
    • Opportunities
  • Untapped Potential in the Emerging Economies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Renal Denervation Devices Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Renal Denervation Devices Market , By Procedure Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Percutaneous Renal Denervation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Radiofrequency Renal Denervation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Ultrasound Renal Denervation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Renal Denervation Devices Market , By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

7. Global Renal Denervation Devices Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • China
      • Japan
      • India
      • Australia
      • ASEAN
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2020-2032,(US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

8. Competitive Landscape

  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Recor Medical, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boston Scientific Corp
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Kona Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Ablative Solutions
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Others
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us